Purification and characterization of hepatitis B virus surface antigen particles produced in Drosophila Schneider-2 cells

被引:23
作者
Deml, L
Schirmbeck, R
Reimann, J
Wolf, H
Wagner, R
机构
[1] Univ Regensburg, Klinikum Regensburg, Inst Med Microbiol, D-93053 Regensburg, Germany
[2] Univ Ulm, Inst Med Microbiol & Immunol, D-89069 Ulm, Germany
关键词
Drosophila Schneider-2 cells; HBsAg; expression antigenicity; immunogenicity;
D O I
10.1016/S0166-0934(99)00022-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The small surface antigen of hepatitis B virus (HBV) was produced in Drosophila melanogaster Schneider-2 (DS-2) cells transfected stably using an inducible Drosophila metallothionein promoter. Selected clonal DS-2 cell-lines expressed and secreted large quantities of HBsAg particles consisting exclusively of non-glycosylated 25 kDa proteins. HBsAg produced by DS-2 cells had physical and biochemical properties very similar to 22 nm particles derived from the human hepatoma cell-line PLC/PRF/5. DS-2 cell-derived HBsAg particles were purified near homogeneity by a strategy based on protein concentration, precipitation and ultracentrifugation. The resulting HBsAg product was < 98% pure. A single immunisation of BALB/c mice with both DS-2 and yeast-cell derived purified HBsAg particles without adjuvants elicited a substantial humoral antibody and class-I restricted cytotoxic T lymphocyte (CTL) response. Adsorbtion of HBsAg particles to aluminium hydroxide resulted in increased levels of HBsAg-specific antibodies. However, CTLs were not elicited by HBsAg/Alum combinations. Thus, stably transfected DS-2 cells provide a useful source for the production of HBV subviral particles for diagnostic and research purposes as well as for novel vaccine development. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:205 / 217
页数:13
相关论文
共 52 条
[11]   INDUCTION OF HIV-1 ENVELOPE (GP120)-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES IN MICE BY RECOMBINANT CHO CELL-DERIVED GP120 IS ENHANCED BY ENZYMATIC REMOVAL OF N-LINKED GLYCANS [J].
DOE, B ;
STEIMER, KS ;
WALKER, CM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2369-2376
[12]   PRODUCTION OF POTENT ANTI-AUSTRALIA ANTIGEN SERA OF HIGH SPECIFICITY AND SENSITIVITY IN GOATS [J].
DREESMAN, GR ;
HOLLINGER, FB ;
MELNICK, JL ;
MCCOMBS, RM .
INFECTION AND IMMUNITY, 1972, 5 (02) :213-+
[13]   THE PREVENTION OF HEPATITIS-B WITH VACCINE - REPORT OF THE CENTERS-FOR-DISEASE-CONTROL MULTI-CENTER EFFICACY TRIAL AMONG HOMOSEXUAL MEN [J].
FRANCIS, DP ;
HADLER, SC ;
THOMPSON, SE ;
MAYNARD, JE ;
OSTROW, DG ;
ALTMAN, N ;
BRAFF, EH ;
OMALLEY, P ;
HAWKINS, D ;
JUDSON, FN ;
PENLEY, K ;
NYLUND, T ;
CHRISTIE, G ;
MEYERS, F ;
MOORE, JN ;
GARDNER, A ;
DOTO, IL ;
MILLER, JH ;
REYNOLDS, GH ;
MURPHY, BL ;
SCHABLE, CA ;
CLARK, BT ;
CURRAN, JW ;
REDEKER, AG .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (03) :362-366
[14]   THE MOLECULAR-BIOLOGY OF THE HEPATITIS-B VIRUSES [J].
GANEM, D ;
VARMUS, HE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :651-693
[15]   CYTOTOXIC T-LYMPHOCYTES INHIBIT HEPATITIS-B VIRUS GENE-EXPRESSION BY A NONCYTOLYTIC MECHANISM IN TRANSGENIC MICE [J].
GUIDOTTI, LG ;
ANDO, K ;
HOBBS, MV ;
ISHIKAWA, T ;
RUNKEL, L ;
SCHREIBER, RD ;
CHISARI, FV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3764-3768
[16]  
HARFORD N, 1983, DEV BIOL STAND, V54, P125
[17]   LARGE SURFACE-PROTEINS OF HEPATITIS-B VIRUS CONTAINING THE PRE-S SEQUENCE [J].
HEERMANN, KH ;
GOLDMANN, U ;
SCHWARTZ, W ;
SEYFFARTH, T ;
BAUMGARTEN, H ;
GERLICH, WH .
JOURNAL OF VIROLOGY, 1984, 52 (02) :396-402
[18]  
HILLEMAN MR, 1983, DEV BIOLOGICALS, V54, P3
[19]   EXPRESSION OF HEPATITIS-B VIRUS SURFACE-ANTIGEN IN YEAST [J].
HITZEMAN, RA ;
CHEN, CY ;
HAGIE, FE ;
PATZER, EJ ;
LIU, CC ;
ESTELL, DA ;
MILLER, JV ;
YAFFE, A ;
KLEID, DG ;
LEVINSON, AD ;
OPPERMANN, H .
NUCLEIC ACIDS RESEARCH, 1983, 11 (09) :2745-2763
[20]  
HSIUNG N, 1984, Journal of Molecular and Applied Genetics, V2, P497